• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Gilead Sciences Inc

+ Add to Watchlist

GILD:US

70.0000 USD 0.7200 1.04%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Gilead Sciences Inc (GILD)

Open: 69.3700 Day's Range: 69.0900 - 70.6400 Volume: 17,548,425
Previous Close: 69.2800 52wk Range: 46.7000 - 84.8800 1-Yr Rtn: +31.65%

Stock Chart for GILD

No chart data available.
  • GILD:US 70.0000
  • 1D
  • 1M
  • 1Y
69.2800
Interactive GILD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GILD

Current P/E Ratio (ttm) 37.3520
Estimated P/E(12/2014) 17.1233
Relative P/E vs. SPX 2.1720
Earnings Per Share (USD) (ttm) 1.8741
Est. EPS (USD) (12/2014) 4.0880
Est. PEG Ratio 0.6659
Market Cap (M USD) 107,649.74
Shares Outstanding (M) 1,537.85
30 Day Average Volume 19,329,828
Price/Book (mrq) 9.4475
Price/Sale (ttm) 9.5541
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GILD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GILD

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

John C MartinChairman/CEOJohn F MilliganPresident/COO
Robin L WashingtonExec VP/CFOJohn G McHutchisonExec Vice President
More Company Profile & Key Executives for GILD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil